February 2022 FDA Recall Drug by Dollar Tree Distribution, Inc.
D-0641-2022 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Dollar Tree Distribution, Inc. on February 18, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Alabama, Arkansas, Louisiana, Mississippi, Missouri, Tennessee and the recall is currently ongoing.

Recall Number: D-0641-2022

Reason for Recall
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.
Initiated
02-18-2022
Reported
03-09-2022
Quantity
Unknown

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dollar Tree Distribution, Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Alabama, Arkansas, Louisiana, Mississippi, Missouri, Tennessee
All Over-The-Counter (OTC) drug products sold by Family Dollar retail stores located in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee.

Batch or Lot Expiration Information

Lot# All drug products sold by Family Dollar retail stores located in AL, AR, LA, MS, MO, and TN from January 1, 2021 to present.